Email Updates

You are here

CDC 4370 (Bangkok Tenofovir Study)

Status
Completed
Phase
III
II
Principal Investigator(s)
Kachit Choopanya, MD
Objective

To assess the safety and efficacy of daily tenofovir to prevent parenteral HIV infection among IDUs.

Prevention Option(s)
PrEP
Study Design
Controlled
Randomized
Double-blind
Arms and Assigned Interventions
Description
Daily dosing
Mode of Delivery
Tablet
Products
TDF
ARMs
Experimental
Description
Daily dosing
Mode of Delivery
Tablet
ARMs
Placebo Comparator
Trial Sponsors
Bangkok Metropolitan Administration Medical College and Vajira Hospital, Thailand Ministry of Health, US CDC
Product Developers
Gilead Sciences, Inc.
June 2005
October 2014
Enrollment
2 413
20
Years
60
Years
Population
Injecting drug users
Sites

Site(s) - Thailand

Thailand